Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes

C. Alhan, T.M. Westers, L.H. van der Helm, C.M. Eeltink, G. Huls, B.I. Witte, F. Buchi, V. Santini, G.J. Ossenkoppele, A.A. van de Loosdrecht

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)207-215
JournalCytometry Part B. Clinical Cytometry
Volume86
Issue number3
DOIs
Publication statusPublished - 2014

Cite this